Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes

被引:1
|
作者
Tohi, Yoichiro [1 ]
Kato, Takuma [1 ]
Matsuda, Iori [1 ]
Honda, Tomoko [1 ]
Osaki, Yu [1 ]
Naito, Hirohito [1 ]
Matsuoka, Yuki [1 ]
Okazoe, Homare [1 ]
Taoka, Rikiya [1 ]
Ueda, Nobufumi [1 ]
Sugimoto, Mikio [1 ]
机构
[1] Kagawa Univ, Fac Med, Dept Urol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan
关键词
active surveillance; quality of life; patient-reported outcomes; prostate cancer; MEN; CRITERIA; THERAPY; PRIAS;
D O I
10.1093/jjco/hyac201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During active surveillance, the health-related quality of life of younger Japanese patients was maintained over time, and the surveillance period was shorter in younger patients compared with older patients. Objective this study aimed to evaluate the active surveillance continuation period, treatment intervention rate and health-related quality of life in younger patients. Methods we prospectively conducted a health-related quality of life survey of patients enrolled in the Prostate Cancer Research International: Active Surveillance-JAPAN study at Kagawa University between January 2010 and December 2020. Health-related quality of life was assessed by mail using a validated Japanese version of the Short-Form 8 Health Survey and Expanded Prostate Cancer Index at active surveillance enrolment and annually thereafter until discontinuation of active surveillance. We divided the patients into two groups, younger (aged <65 years) and older (aged >= 65 years), and compared the two groups. Results of the 84 patients, 22 were in the younger group. The active surveillance continuation period was shorter in the younger group than in the older group. The 3-year treatment intervention rate was higher in the younger group than in the older group. The majority of the reasons for definitive treatment were related to the protocol, which was similar in both groups (80 versus 76%). The sexual summary scores at active surveillance enrolment were higher in the younger group than in the older group. During active surveillance, the younger group and the older group showed no deterioration in all health-related quality of life scores compared with the scores at the enrolment of active surveillance. Conclusions patient-reported health-related quality of life survey indicated that the health-related quality of life of younger Japanese patients was maintained over time during active surveillance, similar to that of older patients.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 50 条
  • [31] Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study
    Tyson, Mark D.
    Alvarez, JoAnn
    Koyama, Tatsuki
    Hoffman, Karen E.
    Resnick, Matthew J.
    Wu, Xiao-Cheng
    Cooperberg, Matthew R.
    Goodman, Michael
    Greenfield, Sheldon
    Hamilton, Ann S.
    Hashibe, Mia
    Paddock, Lisa E.
    Stroup, Antoinette
    Chen, Vivien W.
    Penson, David F.
    Barocas, Daniel A.
    EUROPEAN UROLOGY, 2017, 72 (02) : 307 - 314
  • [32] Patient-Reported Outcomes in Cancer Patients with HIV
    Coghill, Anna E. E.
    Brownstein, Naomi C. C.
    Sinha, Sweta
    Thompson, Zachary J. J.
    Dickey, Brittney L. L.
    Hoogland, Aasha I. I.
    Johnstone, Peter A. A.
    Suneja, Gita
    Jim, Heather S. S.
    CANCERS, 2022, 14 (23)
  • [33] Temporary Health Impact of Prostate MRI and Transrectal Prostate Biopsy in Active Surveillance Prostate Cancer Patients
    Shankar, Prasad R.
    Maturen, Katherine E.
    George, Arvin K.
    Borza, Tudor
    Ellimoottil, Chandy
    Montgomery, Jeffrey S.
    Wei, John T.
    Denton, Brian T.
    Davenport, Matthew S.
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2019, 16 (10) : 1385 - 1392
  • [34] Patient-reported outcomes in clinical studies of patients with hypertrophic cardiomyopathy
    Reza, Nosheen
    Day, Sharlene M.
    Owens, Anjali Tiku
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 80 : 60 - 65
  • [35] Psychological predictors of delayed active treatment following active surveillance for low-risk prostate cancer: The Patient REported outcomes for Prostate cARE prospective cohort study
    Taylor, Kathryn L.
    Luta, George
    Zotou, Vasiliki
    Lobo, Tania
    Hoffman, Richard M.
    Davis, Kimberly M.
    Potosky, Arnold L.
    Li, Tengfei
    Aaronson, David
    Van Den Eeden, Stephen K.
    BJUI COMPASS, 2022, 3 (03): : 226 - 237
  • [36] Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients
    Moryl, Natalie
    Dave, Vinnidhy
    Glare, Paul
    Bokhari, Ali
    Malhotra, Vivek T.
    Gulati, Amitabh
    Hung, Joseph
    Puttanniah, Vinay
    Griffo, Yvona
    Tickoo, Roma
    Wiesenthal, Alison
    Horn, Susan D.
    Inturrisi, Charles E.
    JOURNAL OF PAIN, 2018, 19 (03) : 278 - 290
  • [37] Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients
    Hillebrand, Larissa Elisabeth
    Soeling, Ulrike
    Marschner, Norbert
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (7-8) : 423 - 428
  • [38] Patient-Reported Outcomes in Patients with Cardiomyopathy
    Garcia, Raul Angel
    Benton, Mary C.
    Spertus, John A.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
  • [39] Symptoms as Patient-Reported Outcomes in Cancer Patients Undergoing Immunotherapies
    Mendoza, Tito R.
    IMMUNOTHERAPY, 2ND EDITION, 2018, 995 : 165 - 182
  • [40] The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer
    Xiao, Canhua
    Hurst, Newton
    Movsas, Benjamin
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 377 - 385